ursodeoxycholic acid has been researched along with Morbid Obesity in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 5 (11.63) | 29.6817 |
| 2010's | 14 (32.56) | 24.3611 |
| 2020's | 22 (51.16) | 2.80 |
| Authors | Studies |
|---|---|
| Acherman, YIZ; Boerlage, TCC; Bruin, S; de Brauw, LM; de Castro, SMM; de Vries, CEE; Dijkgraaf, MGW; Fockens, P; Gerdes, VEA; Guman, MSS; Haal, S; Moes, DE; Schouten, M; Schouten, R; van de Laar, AWJM; van Hooft, JE; van Soest, EJ; van Veen, RN; Voermans, RP | 1 |
| Conneely, JB; Fearon, NM; Heneghan, HM; Kearns, EC; Kennedy, CA | 1 |
| Andalib, A; Barzin, M; Hosseinpanah, F; Khalaj, A; Mahdavi, M; Mousapour, P; Valizadeh, M | 1 |
| Aljarad, F; Ameen, MA; Balamoun, H; Elewa, A; Elias, AA; Hamdy, A; Helal, A; Hussein, AM; Mahmoud, AA; Mohamed, US; Moustafa, A; Nashaat, A; Omar, HSE; Omar, T; Salman, A; Salman, MA; Shaaban, HE; Tourky, M | 1 |
| Bruin, S; Dijkgraaf, MGW; Fockens, P; Gerdes, VEA; Guman, MSS; Haal, S; Hutten, BA; Schouten, R; van Veen, RN; Voermans, RP | 1 |
| Almalki, OM; Chen, JC; Chen, SC; Han, ML; Lee, MH; Lee, WJ; Wu, CC | 1 |
| Dijkgraaf, PMGW; Gerdes, VEA; Guman, MSS; Haal, S; Hutten, BA; Maurits de Brauw, L; Nieuwdorp, PM; Nuijen, B; Schouten, R; van Veen, RN; Voermans, RP | 1 |
| Dai, C; Dai, S; Fu, R; Hong, J; Jin, Q; Ying, J | 1 |
| Alves, A; Dupont, B; Menahem, B; Mulliri, A | 1 |
| de Brauw, LM; Dijkgraaf, MGW; Fockens, P; Gerdes, VEA; Guman, MSS; Haal, S; Schouten, R; van Veen, RN; Voermans, RP | 2 |
| Hashimoto, K; Ikejiri, K; Kudou, K; Kusumoto, E; Kusumoto, T; Nagao, Y; Nambara, S; Sakaguchi, Y; Tsuda, Y | 1 |
| Alamro, N; Almuqati, A; Azhar, W; Azhri, AS; Azzeh, F; Ghafouri, K; Qadhi, A | 1 |
| Brodie, J; Ellsmere, J; Evans, B; Hossain, I; Lawlor, D; Murphy, R; O'Brien, E; Pace, D; Tedman-Aucoin, K; Twells, L | 1 |
| Acherman, YIZ; Gerdes, VEA; Guman, MSS; Haal, S; Nieuwdorp, M; van de Laar, AWL; Voermans, RP | 1 |
| Becerra, AZ; Coogan, AC; Krishnan, V; Omotosho, P; Sarran, M; Schimpke, S; Skertich, NJ; Torquati, A; Williams, MD | 1 |
| Best, LMJ; Nageswaran, H; Patel, AG; Shanti, H; Sharma, A | 1 |
| Arredondo-Saldaña, G; Gibbs, KE; Leal-Isla-Flores, V; Leyva-Alvizo, A; Petrick, A; Romanelli, J; Soriano, IS; Sudan, R | 1 |
| Christodoulidis, G; Magouliotis, DE; Zacharoulis, D | 1 |
| D'Antonio, D; Del Genio, G; Dell'Isola, C; Docimo, L; Gambardella, C; Lucido, FS; Pizza, F; Tolone, S | 1 |
| Alimoğulları, M; Buluş, H | 1 |
| Cho, IR; Choi, JH; Kim, YT; Lee, SH; Paik, WH; Ryu, JK | 1 |
| Auer, N; Castro, RE; Herac, M; Marschall, HU; Mueller, M; Rodrigues, CMP; Thorell, A; Trauner, M | 1 |
| Chatedaki, C; Magouliotis, DE; Sioka, E; Svokos, AA; Svokos, KA; Tasiopoulou, VS; Zacharoulis, D | 1 |
| Acherman, YIZ; Boerlage, TCC; Bruin, S; de Vries, CEE; Dijkgraaf, MG; Fockens, P; Gerdes, VEA; Haal, S; Maurits de Brauw, L; Moes, DE; Schouten, R; van de Laar, AWJM; van Veen, R; van Wagensveld, BA; Voermans, RP | 1 |
| Archid, R; Della Penna, A; Hilbert, J; Königsrainer, A; Lange, J; Quante, M | 1 |
| Babadopulos, RFAL; Castro Filho, HF; Machado, FHF; Moraes Filho, MO; Rocha, HAL; Rocha, JLC | 1 |
| Calabrese, D; Coupaye, M; Ledoux, S; Sami, O; Siauve, N | 1 |
| Gamal, K; Khalil, AH; Nabil, TM | 1 |
| Claudel, T; Einarsson, C; Fauler, G; Hoesel, B; Jha, P; Koefeler, H; Lackner, C; Marschall, HU; Mueller, M; Stojakovic, T; Thorell, A; Trauner, M | 1 |
| Bisson, WH; Gonzalez, FJ; Jiang, C; Patterson, AD | 1 |
| Adams, LB; Chang, C; Kim, Y; Liu, P; Pope, J; Yates, A | 1 |
| Abdallah, E; Abdelshafy, M; Elfeki, H; Elgendy, H; Elghadban, H; Elshobaky, A; Emile, SH; Fikry, M; Lotfy, A; Thabet, W; Youssef, M | 1 |
| Daez, ML; Espinosa, WZ; Ong, JP; Talingdan-Te, MC; Uy, MC | 1 |
| Fickert, P; Lackner, C; Marschall, HU; Thorell, A; Trauner, M; Wagner, M; Zollner, G | 1 |
| Afonso, MB; Borralho, PM; Castro, RE; Cortez-Pinto, H; Ferreira, DM; Machado, MV; Rodrigues, CM | 1 |
| Benarroch-Gampel, J; Boyd, CA; Ho, V; Lairson, DR; Riall, TS; Sheffield, KM | 1 |
| Hamilton, EC; Jones, DB; Provost, DA; Scott, DJ; Sims, TL; Villegas, L | 1 |
| Hell, E; Lang, B; Lengauer, E; Miller, K | 1 |
| Durian, MF; Hesp, WL; Kiewiet, RM; van Leersum, M; van Vliet, AC | 1 |
| Inglis, FG; Shaffer, EA; Worobetz, LJ | 1 |
| Biskupiak, JE; Nash, DB; Shoheiber, O | 1 |
| Allos, TM; Chapman, WC; Debelak, JP; Shyr, Y; Wright, JK; Wudel, LJ | 1 |
8 review(s) available for ursodeoxycholic acid and Morbid Obesity
| Article | Year |
|---|---|
The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials.
Topics: Bariatric Surgery; Gallstones; Humans; Obesity, Morbid; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss | 2022 |
Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis.
Topics: Bariatric Surgery; Gallstones; Humans; Incidence; Obesity, Morbid; Postoperative Period; Ursodeoxycholic Acid | 2022 |
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials.
Topics: Bariatric Surgery; Cholecystectomy; Gallstones; Humans; Obesity, Morbid; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2022 |
Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
Topics: Bariatric Surgery; Gallstones; Gastroplasty; Humans; Obesity, Morbid; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2023 |
Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery.
Topics: Bariatric Surgery; Cholagogues and Choleretics; Gallbladder Diseases; Humans; Minimally Invasive Surgical Procedures; Obesity, Morbid; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: A systematic review and meta-analysis.
Topics: Cholecystectomy; Gallstones; Humans; Obesity, Morbid; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis.
Topics: Adult; Bariatric Surgery; Chemoprevention; Cholecystectomy; Gallstones; Humans; Obesity, Morbid; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
Topics: Bariatric Surgery; Cholagogues and Choleretics; Cholelithiasis; Humans; Obesity, Morbid; Postoperative Complications; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid; Weight Loss | 2008 |
18 trial(s) available for ursodeoxycholic acid and Morbid Obesity
| Article | Year |
|---|---|
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Topics: Adult; Bariatric Surgery; Case-Control Studies; Cholagogues and Choleretics; Cholelithiasis; Double-Blind Method; Female; Gastrectomy; Gastric Bypass; Humans; Laparoscopy; Male; Middle Aged; Netherlands; Obesity, Morbid; Outcome Assessment, Health Care; Placebos; Postoperative Complications; Safety; Treatment Outcome; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic acid for the prevention of gall stones after laparoscopic sleeve gastrectomy: a prospective controlled study.
Topics: Gallstones; Gastrectomy; Humans; Laparoscopy; Obesity, Morbid; Postoperative Complications; Prospective Studies; Ursodeoxycholic Acid; Weight Loss | 2022 |
Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.
Topics: Bariatric Surgery; Gallstones; Humans; Obesity, Morbid; Risk Factors; Ursodeoxycholic Acid | 2022 |
Probiotics for gallstone prevention in patients with bariatric surgery: A prospective randomized trial.
Topics: Adult; Bariatric Surgery; Diabetes Mellitus, Type 2; Female; Gallstones; Humans; Male; Obesity, Morbid; Probiotics; Prospective Studies; Ursodeoxycholic Acid | 2022 |
Factors associated with adherence to ursodeoxycholic acid or placebo in patients after bariatric surgery.
Topics: Bariatric Surgery; Female; Gastrectomy; Gastric Bypass; Humans; Obesity, Morbid; Postoperative Complications; Ursodeoxycholic Acid | 2022 |
Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
Topics: Cost-Benefit Analysis; Gallstones; Gastrectomy; Gastric Bypass; Humans; Obesity, Morbid; Ursodeoxycholic Acid | 2022 |
Ursodeoxycholic Acid Use After Bariatric Surgery: Effects on Metabolic and Inflammatory Blood Markers.
Topics: Adult; Bariatric Surgery; Cross-Sectional Studies; Female; Gallstones; Glycated Hemoglobin; Humans; Inflammation; Lipids; Male; Middle Aged; Obesity, Morbid; Ursodeoxycholic Acid | 2023 |
The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
Topics: Gastric Bypass; Humans; Obesity, Morbid; Prospective Studies; Quality of Life; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Topics: Bariatric Surgery; Cholelithiasis; Gastrectomy; Gastric Bypass; Humans; Netherlands; Obesity, Morbid; Quality of Life; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients.
Topics: Apoptosis; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Liver; MicroRNAs; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Oxidative Stress; Sweden; Transcription Factor CHOP; Unfolded Protein Response; Ursodeoxycholic Acid | 2018 |
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Topics: Cholagogues and Choleretics; Clinical Protocols; Cost-Benefit Analysis; Double-Blind Method; Follow-Up Studies; Gallstones; Gastric Bypass; Humans; Obesity, Morbid; Postoperative Complications; Quality of Life; Ursodeoxycholic Acid | 2017 |
Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
Topics: Bile Acids and Salts; Humans; Intra-Abdominal Fat; Lipid Metabolism; Liver; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Oleic Acid; Receptors, Cytoplasmic and Nuclear; Stearoyl-CoA Desaturase; Ursodeoxycholic Acid | 2015 |
Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
Topics: Adult; Female; Gallstones; Gastrectomy; Humans; Male; Middle Aged; Obesity, Morbid; Patient Compliance; Postoperative Period; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2016 |
Ursodeoxycholic acid for treatment of fatty liver disease and dyslipidemia in morbidly obese patients.
Topics: Adult; Dyslipidemias; Fatty Liver; Female; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Obesity, Morbid; Ursodeoxycholic Acid | 2011 |
Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Cholagogues and Choleretics; Cholecystolithiasis; Double-Blind Method; Female; Gallstones; Gastroplasty; Humans; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Prospective Studies; Ursodeoxycholic Acid | 2003 |
The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
Topics: Adult; Cholelithiasis; Female; Gastroplasty; Humans; Incidence; Male; Middle Aged; Obesity, Morbid; Ursodeoxycholic Acid; Weight Loss | 1993 |
Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction.
Topics: Adult; Aged; Cholagogues and Choleretics; Cholelithiasis; Cost-Benefit Analysis; Diet, Reducing; Female; Gastric Bypass; Humans; Male; Middle Aged; Obesity, Morbid; Ursodeoxycholic Acid | 1997 |
Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
Topics: Adult; Cholecystectomy; Cholelithiasis; Double-Blind Method; Female; Gastric Bypass; Humans; Ibuprofen; Male; Obesity, Morbid; Patient Compliance; Pilot Projects; Placebos; Time Factors; Ultrasonography; Ursodeoxycholic Acid; Weight Loss | 2002 |
17 other study(ies) available for ursodeoxycholic acid and Morbid Obesity
| Article | Year |
|---|---|
Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
Topics: Bariatric Surgery; Gallstones; Humans; Iran; Laparoscopy; Obesity; Obesity, Morbid; Postoperative Complications; Ursodeoxycholic Acid; Weight Loss | 2022 |
Association Between Anti-Helicobacter pylori Antibody Seropositive and De Novo Gallstone Formation After Laparoscopic Sleeve Gastrectomy for Japanese Patients with Severe Obesity.
Topics: Gallstones; Gastrectomy; Humans; Japan; Laparoscopy; Obesity, Morbid; Postoperative Complications; Retrospective Studies; Ursodeoxycholic Acid | 2022 |
Factors influencing body weight one year after bariatric surgery.
Topics: Bariatric Surgery; Body Mass Index; Gallstones; Humans; Obesity, Morbid; Retrospective Studies; Ursodeoxycholic Acid; Weight Loss | 2023 |
Ursodeoxycholic acid for prevention of gallstone disease after laparoscopic sleeve gastrectomy: an Atlantic Canada perspective.
Topics: Gallstones; Gastrectomy; Humans; Laparoscopy; Obesity, Morbid; Postoperative Complications; Retrospective Studies; Ursodeoxycholic Acid | 2023 |
Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.
Topics: Bariatric Surgery; Cholecystitis; Gallstones; Gastrectomy; Gastric Bypass; Humans; Obesity, Morbid; Postoperative Complications; Retrospective Studies; Ursodeoxycholic Acid | 2023 |
The Necessity for Routine Administration of Ursodeoxycholic Acid After Bariatric Surgery.
Topics: Bariatric Surgery; Bariatrics; Cholelithiasis; Gastric Bypass; Humans; Incidence; Obesity, Morbid; Ursodeoxycholic Acid | 2020 |
Effectiveness of ursodeoxycholic acid treatment in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Topics: Child, Preschool; Gallstones; Gastrectomy; Humans; Infant; Laparoscopy; Obesity, Morbid; Retrospective Studies; Ursodeoxycholic Acid | 2021 |
Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Topics: Adult; Aged; Asymptomatic Diseases; Bariatric Surgery; Combined Modality Therapy; Comorbidity; Drug Administration Schedule; Female; Follow-Up Studies; Gallstones; Humans; Laparoscopy; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Postoperative Period; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2019 |
Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.
Topics: Adult; Anthropometry; Cholagogues and Choleretics; Comorbidity; Female; Gallstones; Gastric Bypass; Humans; Male; Obesity, Morbid; Postoperative Complications; Postoperative Period; Prospective Studies; Stomach; Ursodeoxycholic Acid | 2019 |
Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Topics: Adult; Bariatric Surgery; Cholagogues and Choleretics; Cholecystectomy; Drug Administration Schedule; Female; Gallstones; Gastrectomy; Humans; Incidence; Male; Middle Aged; Obesity, Morbid; Postoperative Care; Postoperative Complications; Risk Factors; Ultrasonography; Ursodeoxycholic Acid | 2019 |
Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
Topics: Administration, Oral; Adult; Bariatric Surgery; Cholagogues and Choleretics; Cholelithiasis; Female; Gastrectomy; Humans; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Prospective Studies; Ursodeoxycholic Acid; Young Adult | 2019 |
Inhibition of farnesoid X receptor signaling shows beneficial effects in human obesity.
Topics: Bile Acids and Salts; Humans; Lipid Metabolism; Obesity, Morbid; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2015 |
Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy.
Topics: Adult; Bariatric Surgery; Cholelithiasis; Female; Gastrectomy; Humans; Laparoscopy; Male; Obesity, Morbid; Postoperative Complications; Retrospective Studies; Risk Factors; Ursodeoxycholic Acid; Young Adult | 2017 |
miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Topics: Animals; Apoptosis; Biopsy; Fatty Liver; Hepatocytes; Humans; Liver; Male; MicroRNAs; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Signal Transduction; Sirtuin 1; Transcription, Genetic; Tumor Suppressor Protein p53; Ursodeoxycholic Acid | 2013 |
Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity.
Topics: Adult; Cholecystectomy; Comorbidity; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Diagnosis-Related Groups; Gallbladder Diseases; Gastric Bypass; Humans; Incidence; Length of Stay; Obesity, Morbid; Postoperative Complications; Preoperative Care; Texas; Ultrasonography; Ursodeoxycholic Acid | 2012 |
Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
Topics: Adult; Anastomosis, Roux-en-Y; Cholagogues and Choleretics; Cholecystectomy, Laparoscopic; Cholelithiasis; Female; Gastric Bypass; Humans; Intraoperative Care; Laparoscopy; Male; Middle Aged; Obesity, Morbid; Patient Compliance; Postoperative Complications; Treatment Outcome; Ultrasonography, Interventional; Ursodeoxycholic Acid | 2003 |
[Gallstones following considerable weight loss and recommendations for their prevention].
Topics: Adult; Female; Gallstones; Humans; Male; Middle Aged; Obesity, Morbid; Postoperative Complications; Treatment Outcome; Ursodeoxycholic Acid; Weight Loss | 2004 |